Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020
Copyright © 2020 SPLF. Published by Elsevier Masson SAS. All rights reserved..
The French-language Respiratory Medicine Society (SPLF) proposes a guide for the follow-up of patients who have presented with SARS-CoV-2 pneumonia. The proposals are based on known data from previous epidemics, on acute lesions observed in SARS-CoV-2 patients and on expert opinion. This guide proposes a follow-up based on three categories of patients: (1) patients managed outside hospital for possible or proven SARS-CoV-2 infection, referred by their physician for persistent dyspnoea; (2) patients hospitalized for SARS-CoV-2 pneumonia in a medical unit; (3) patients hospitalized for SARS-CoV-2 pneumonia in an intensive care unit. The subsequent follow-up will have to be adapted to the initial assessment. This guide emphasises the possibility of others causes of dyspnoea (cardiac, thromboembolic, hyperventilation syndrome…). These proposals may evolve over time as more knowledge becomes available.
| Errataetall: |
CommentIn: Rev Mal Respir. 2020 Jun;37(6):441-442. - PMID 32564800 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Revue des maladies respiratoires - 37(2020), 6 vom: 15. Juni, Seite 505-510 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Guide pour le suivi respiratoire des patients ayant présenté une pneumonie à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de pneumologie de langue française. Version du 10 mai 2020 |
|---|
| Beteiligte Personen: |
Andrejak, C [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID |
|---|
| Anmerkungen: |
Date Completed 26.06.2020 Date Revised 10.01.2021 published: Print-Electronic CommentIn: Rev Mal Respir. 2020 Jun;37(6):441-442. - PMID 32564800 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.rmr.2020.05.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309935415 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309935415 | ||
| 003 | DE-627 | ||
| 005 | 20231225135013.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.rmr.2020.05.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM309935415 | ||
| 035 | |a (NLM)32410773 | ||
| 035 | |a (PII)S0761-8425(20)30163-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Andrejak, C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020 |
| 246 | 3 | 3 | |a Guide pour le suivi respiratoire des patients ayant présenté une pneumonie à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de pneumologie de langue française. Version du 10 mai 2020 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.06.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Rev Mal Respir. 2020 Jun;37(6):441-442. - PMID 32564800 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 SPLF. Published by Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a The French-language Respiratory Medicine Society (SPLF) proposes a guide for the follow-up of patients who have presented with SARS-CoV-2 pneumonia. The proposals are based on known data from previous epidemics, on acute lesions observed in SARS-CoV-2 patients and on expert opinion. This guide proposes a follow-up based on three categories of patients: (1) patients managed outside hospital for possible or proven SARS-CoV-2 infection, referred by their physician for persistent dyspnoea; (2) patients hospitalized for SARS-CoV-2 pneumonia in a medical unit; (3) patients hospitalized for SARS-CoV-2 pneumonia in an intensive care unit. The subsequent follow-up will have to be adapted to the initial assessment. This guide emphasises the possibility of others causes of dyspnoea (cardiac, thromboembolic, hyperventilation syndrome…). These proposals may evolve over time as more knowledge becomes available | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a COVID | |
| 650 | 4 | |a CT scan | |
| 650 | 4 | |a Fibrose | |
| 650 | 4 | |a Fibrosis | |
| 650 | 4 | |a Follow-up | |
| 650 | 4 | |a Plethysmography | |
| 650 | 4 | |a Pléthysmographie | |
| 650 | 4 | |a Scanner | |
| 650 | 4 | |a Suivi | |
| 700 | 1 | |a Blanc, F-X |e verfasserin |4 aut | |
| 700 | 1 | |a Costes, F |e verfasserin |4 aut | |
| 700 | 1 | |a Crestani, B |e verfasserin |4 aut | |
| 700 | 1 | |a Debieuvre, D |e verfasserin |4 aut | |
| 700 | 1 | |a Perez, T |e verfasserin |4 aut | |
| 700 | 1 | |a Philippe, B |e verfasserin |4 aut | |
| 700 | 1 | |a Plantier, L |e verfasserin |4 aut | |
| 700 | 1 | |a Schlemmer, F |e verfasserin |4 aut | |
| 700 | 1 | |a Sesé, L |e verfasserin |4 aut | |
| 700 | 1 | |a Stach, B |e verfasserin |4 aut | |
| 700 | 1 | |a Uzunhan, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Zanetti, C |e verfasserin |4 aut | |
| 700 | 1 | |a Zysman, M |e verfasserin |4 aut | |
| 700 | 1 | |a Raherison, C |e verfasserin |4 aut | |
| 700 | 1 | |a Maitre, B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue des maladies respiratoires |d 1988 |g 37(2020), 6 vom: 15. Juni, Seite 505-510 |w (DE-627)NLM012622443 |x 1776-2588 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2020 |g number:6 |g day:15 |g month:06 |g pages:505-510 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rmr.2020.05.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2020 |e 6 |b 15 |c 06 |h 505-510 | ||